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follow-up (mean [SD] change from baseline, 1.8 [0.8]; from 1
year, −0.003 [0.6]). Adjusted mean between-group differ-
ence in change from baseline was −0.03 (95% CI, −0.25 to
0.19; P = .79) and from 1 year was −0.03 (95% CI, −0.23 to
0.17; P = .76). No between-group differences were found in
the secondary outcomes (Table 2).
Discussion |Toour knowledge, this is the first randomized trial
to evaluate long-term outcomes of CTS surgery. After amean
follow-up of 12.8 years after CTS surgery, there were no sig-
nificant differences betweenopenandendoscopic carpal tun-
nel release. The large symptom and functional improve-
ments and high level of patient satisfaction achieved with
surgery were durable and few patients had undergone fur-
ther surgery.
Study limitations include a single institution in Sweden
and unknown generalizability. Our long-term follow-up was
limited to patient-reported outcomes, which are central in
CTS and were consistent across several measures with
established reliability and validity. The results should help
clinicians and patients in making treatment decisions.
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COMMENT&RESPONSE
Treatment of Uncomplicated Acute Appendicitis
To the Editor The use of a noninferiority design in the Appen-
dicitis Acuta (APPAC) trial allowed for the assessment of
primary outcomes specific to each treatment.1 However, we
believe that the chosen outcomes were not equally
patient-centric, leading to the erroneous conclusion that an-
tibiotics did not meet the prespecified criterion for noninfe-
riority compared with appendectomy.1
The primary end point in the antibiotic-treated group of
“discharge fromthehospitalwithout theneed for surgery and
norecurrentappendicitisduringa 1-year follow-upperiod”was
patient-centric andanswers thepatient’squestion: “If I choose
to be treated with antibiotics, what is the chance that I will
eventuallyneedanappendectomy?”However, theprimaryend
point for the surgical groupof “successful completionof anap-
pendectomy” is irrelevant to patients who rightfully assume
that anappendectomywill successfully remove theappendix.1
Patients undergoing an appendectomy are typically con-
cerned with the risk of postoperative complications and the
extent of postoperative disability.
Therefore, a more patient-centric end point would have
beendevelopmentof apostoperative complication,whichan-
swers thepatient’s question: “If I choose to be treatedwith an
appendectomy, what is the chance I will have a complication
fromsurgery?”Whenapplying this outcome, antibioticswere
within the predetermined noninferiority margin (24%) be-
cause there was a 20% complication rate in the appendec-
tomy group and a 27% failure rate in the antibiotic group. In
addition, consistentwith previous randomized clinical trials,
the APPAC trial confirmed the safety of nonoperative man-
agement by demonstrating no difference in rates of compli-
cated or perforated appendicitis between the 2 groups.2
Applying the results of theAPPAC trial in theUnitedStates
will be difficult because the surgical group underwent open
appendectomies and the antibiotic group received 3 days of
intravenous antibiotics. The standard of care in the United
States for patients with uncomplicated appendicitis is to un-
dergoa laparoscopic appendectomywitheither same-daydis-
charge or discharge on the first postoperative day. Early re-
sults fromaUS study in children demonstrated the feasibility
of nonoperativemanagement of uncomplicated appendicitis
using24hours of intravenous antibioticswith improvedqual-
ity of life and fewer disability days compared with laparo-
scopic appendectomy.3
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Results from trials of nonoperative management sug-
gest that 3 of 4 patients with uncomplicated appendicitis
treated with antibiotics can avoid surgery.1,2 Because
patient preferences will differ based on which outcomes are
most important to them, future studies investigating
nonoperative management should incorporate relevant
patient-centric outcomes, such as disability, quality of life,
and costs associated with health care, to better inform deci-
sion making.
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To the Editor The APPAC trial1 successfully recruited and ran-
domized a large number of patients with uncomplicated ap-
pendicitis into surgical or antibiotic treatment groups. Even
though the results support antibiotic treatment as a viable al-
ternative to surgery for uncomplicated appendicitis, such a
change in practice needs to be viewed in the context of the
global increase in antimicrobial resistance.2
Can the authors provide any information on the ecology
of antimicrobial susceptibility within the study population,
such as from microbiological analysis of infected appendi-
ces removed in the surgical group of the study? Were ertap-
enem and levofloxacin chosen with this in mind, or would
antibiotics with narrower spectrums have been an alterna-
tive? “Last-line” broad-spectrum carbapenem antibiotics
are often reserved for the most vulnerable patients, such as
those with neutropenic sepsis, and the increase in carbap-
enem resistance2 puts an onus on clinicians to minimize
selective pressure for resistance to emerge by limiting their
use to patients with the greatest need.3
The duration of antibiotic therapy in the APPAC trial
(median of 10 days) is also relatively long. The Study to
Optimize Peritoneal Infection Therapy4 demonstrated that,
following effective source control, a short course of antibi-
otics (median of 4 days) was adequate. In our opinion,
source control remains a key component of both individual
patient care and broader antimicrobial stewardship.
The majority of appendectomies in the APPAC trial were
open procedures with only 5.5% being performed laparo-
scopically. Increased use of laparoscopic appendectomies
may concurrently reduce complication rates and restrict
antibiotic use.5 Antimicrobials are a powerful but precious
resource, and stewardship of their use needs to be consid-
ered on a wider scale and remains a cornerstone of the
global battle against antimicrobial resistance.
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To the EditorWe believe the results of the APPAC trial1 should
be interpreted and used with caution despite it being a ran-
domized trial. First, there is concern over the increasing
global problem of antibiotic resistance2; triple therapy,
including broad-spectrum carbapenem antibiotics, such
as ertapenem, for appendicitis seems like overtreatment.
Use of carbapenem antibiotics (once reserved for patients
in the intensive care unit setting against multiresistant
gram-negative bacteria) have produced resistant Enterobac-
teriaceace.
Second, the use of low-dose computed tomographic (CT)
scanning for thediagnosisofuncomplicatedappendicitis is still
radiation to the patient that can be avoided. In the United
Kingdom, routine imaging to diagnose appendicitis is not ad-
vocated. The use of CT scanning is limited to diagnostic di-
lemmas, atypicalhistories, orpatients inanagegroup inwhich
colonic malignancy needs to be excluded.
Third, most middle- and high-income countries perform
laparoscopic appendectomies rather than open ones.
Faiz et al3 reported in a UK study that the 1-year mortality
rates were higher with open appendectomies compared
with laparoscopic appendectomies (0.64% vs 0.29%,
respectively; P < .001) over a 10-year period. Therefore,
using open appendectomy as the surgical standard is
flawed. The authors stated that the open approach was cho-
sen for global generalization of the study, but such general-
ization is not possible because low-income countries would
not be able to afford the costly antibiotic regime, hospital
admission, and loss of earnings.
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Fourth, the cost of the conservative method (summing
up the antibiotics, CT scanning, hospital stay, and follow-up
based on the UK National Health Service) would be approxi-
mately $2300, given the national average bed cost of $470,4
without including the potential cost of patients requiring
surgery within 1 year. The cost of care in the United King-
dom for a laparoscopic appendectomy is approximately
$3100 with a stay of less than 2 days.4,5 Therefore, treating
uncomplicated appendicitis with antibiotics may not be
cost-effective and should be selective based on risks and
patient choice.
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In ReplyTheAPPAC trial tested the hypothesis that uncompli-
cated acute appendicitis can be successfully treated with an-
tibioticsbycomparingantibiotic therapywithemergencyopen
appendectomy. There is an intrinsic difficulty in defining a
commonprimaryoutcome for thesedissimilar treatments.Al-
though Drs Minneci and Deans advocate for more patient-
centricoutcomes,weaimedto identifyaclearandconcisedefi-
nition of efficacy (ie, resolution of acute appendicitis) that
would apply to both treatments.
Open or laparoscopic appendectomy cures appendicitis.
To enable a fair comparison, we aimed to standardize both
treatmentprocedures for efficacy asmuchaspossible. To suc-
ceed, theantibioticmustprovidebroad-spectrumcoverage for
all thepathogens thatmightcauseappendicitis.Themostcom-
monorganism inacute appendicitis isEscherichia coli, and the
selectionof antibiotics should cover both aerobic and anaero-
bic bacteria. The selection of antibiotics presented a limita-
tion in the trial by Vons et al1 because amoxicillin-clavulanic
acid was used to treat appendicitis despite its limited cover-
age for E coli.
To answerDrs Pollara andMarks andDrAlfa-Wali and col-
leagues, we used ertapenem in our study because it effec-
tively treatsserious intra-abdominal infections,providesbroad-
spectrumcoverage, andonly requires a single,dailydose.2The
total durationof the antibiotic therapy inour trialwas 10days,
including 3-day intravenous ertapenem, resulting in a longer
hospital stay in the antibiotic group. This was predefined in
the protocol for monitoring of the antibiotic group to ensure
patient safety in the trial.
However, shortening thehospital staymaybe feasiblewith
the use of narrower-spectrum antibiotics and a shorter dura-
tion of antibiotic therapy. Themajority (73%) of patientswith
uncomplicated acute appendicitis were successfully treated
with antibiotics andnoneof the patients treated initiallywith
antibiotics and later with appendectomy had major compli-
cations.
Weagree that future studiesof antibiotic treatment for ap-
pendicitis should seek efficacy while using antibiotics with a
more-restricted antibacterial spectrum and shorter treat-
ment duration, which will also affect the health economics.
We are performing a cost analysis of the APPAC trial, but the
final cost-effectivenesscomparisonbetweenantibiotic therapy
and appendectomy needs to incorporate both optimized an-
tibiotic treatment andoptimized surgery (ie, laparoscopic ap-
pendectomy) as noted in all the letters.
Alfa-Wali and colleagues are also concerned about theuse
of CT for diagnosis. Thediagnostic accuracy of CT imaging for
acute appendicitis is almost perfect. Use of CT reduces the
negative appendectomyrate, improvingpatient carebyavoid-
ing unnecessary surgery, and resulting in more efficient use
of hospital resources.3 In the Netherlands, a guideline for
imaging for suspectedappendicitiswas implemented in2010,
resulting in both a reducednegative appendectomy rate (23%
vs6%)andadecrease inaveragecostperpatientby$650.4Con-
cerns regarding radiation exposuremay beminimized by use
of low-dose CT.5
The optimal use of antibiotic therapy regarding both
spectrum and duration of the treatment in patients with
uncomplicated acute appendicitis needs to be prospectively
evaluated in a large patient series including assessment of
relevant patient-centric outcomes. Spontaneous resolution
of appendicitis presents a possible bias for antibiotic treat-
ment for acute appendicitis and a double-blind, placebo-
controlled randomized clinical trial is needed to differenti-
ate these effects.
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Failure to Report Financial Disclosure Information
To the Editor This is in reference to my Viewpoint article in
JAMA1 andmy letter in response to Drs Lee andMacdonald.2
Due to my misinterpretation of the requirements for report-
ing of potential conflicts of interest, I neglected to cite the fol-
lowing disclosures.
I have received research funding from Amarin Pharma-
ceuticals, consulting fees fromAmgen and Sanofi, and speak-
er’s honoraria from Janssen and Merck.
I regret this oversight and have now completed and sub-
mitted revised ICMJE forms. Both articles have been cor-
rected online.
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CORRECTION
OmittedFinancialDisclosures: In theViewpoint “DecipheringCholesterol Treat-
ment Guidelines: A Clinician’s Perspective” published in theMarch 10, 2015, issue
of JAMA,1 and in the subsequent reply letter entitled “Clinician Understanding of
Cholesterol TreatmentGuidelines” published in the June 16, 2015, issueof JAMA,2
the author neglected to cite conflict of interest disclosures. Dr Ganda reports re-
ceivingresearchfundingfromAmarinPharmaceuticals, consultingfees fromAmgen
and Sanofi, and speaker’s honoraria from Janssen andMerck. These articleswere
corrected online.
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Incorrect Title for Table: In the Review article entitled “Septic Shock: Advances
inDiagnosis and Treatment” published in theAugust 18, 2015, issue of JAMA,1 the
title of a table was incorrectly printed. The title, which read “Table 1. Major Ad-
vances in the Diagnosis and Treatment of Traumatic and Septic Shock” should be
“Table 1.Major Advances in theDiagnosis andTreatment of Septic Shock.” This ar-
ticle was corrected online.
1. Seymour CW, Rosengart MR. Septic shock: advances in diagnosis and
treatment. JAMA. 2015;314(7):708-717.
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